Publication | Closed Access

Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic cancer

NanomedicinePancreatic CancerSirna-directed Kras OncogeneMedicineCell DeathTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyTumor BiologyArsenic-induced Apoptosis